Vivo Capital, LLC Avadel Pharmaceuticals PLC Transaction History
Vivo Capital, LLC
- $677 Million
- Q2 2024
A detailed history of Vivo Capital, LLC transactions in Avadel Pharmaceuticals PLC stock. As of the latest transaction made, Vivo Capital, LLC holds 3,972,099 shares of AVDL stock, worth $50.6 Million. This represents 8.25% of its overall portfolio holdings.
Number of Shares
3,972,099
Previous 3,972,099
-0.0%
Holding current value
$50.6 Million
Previous $67.1 Million
16.76%
% of portfolio
8.25%
Previous 8.97%
Shares
8 transactions
Others Institutions Holding AVDL
# of Institutions
14Shares Held
7.03MCall Options Held
0Put Options Held
0-
Tri Locum Partners LP New York, NY1.19MShares$15.2 Million4.32% of portfolio
-
Bio Impact Capital LLC Cambridge, MA783KShares$9.99 Million1.77% of portfolio
-
Knoll Capital Management, LLC Miami, FL600KShares$7.65 Million5.7% of portfolio
-
Knott David M Jr Syosset, NY333KShares$4.25 Million1.87% of portfolio
-
Schulhoff & CO Inc137KShares$1.75 Million0.93% of portfolio
About AVADEL PHARMACEUTICALS PLC
- Ticker AVDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 60,581,300
- Market Cap $772M
- Description
- Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...